We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
From the Centers for Disease Control and Prevention |

Pertussis in an Infant Adopted From Russia—May 2002 FREE

JAMA. 2002;288(1):40. doi:10.1001/jama.288.1.40-JWR0703-3-1.
Text Size: A A A
Published online

MMWR. 2002;51:394-395

On May 2, 2002, the North Carolina Department of Health and Human Services notified CDC about an infant aged 10 months adopted from Russia who had culture-confirmed pertussis diagnosed. On April 8, the adoptive parents picked him up in the orphan ward at hospital A in Bryansk and noticed that the child had upper respiratory congestion and cough. The adoptive parents reported that the infant had not received any vaccinations and that another infant living in the same room in hospital A had a severe cough. The adopted infant subsequently was examined by a local physician, who diagnosed his condition as a "cold," and the infant was taken to the U.S. Embassy in Moscow, where the parents were interviewed for an immigrant visa for the child.

On April 24, the infant and his parents traveled from Moscow to Raleigh, North Carolina, through New York on commercial airline flights. On April 26, the infant was seen as an outpatient at a local clinic; a culture of a nasopharyngeal swab confirmed infection with Bordetella pertussis. The infant improved after treatment with clarithromycin and was administered the first dose of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). The parents were placed on azithromycin for prophylaxis.

CDC is collaborating with the U.S. Embassy, adoption agencies, visa applicant medical clinics in Moscow, and the airline to identify and notify persons who might have been exposed to the infant during his communicable period. The airline is working to identify those passengers who might have been exposed to the infant during his flights to North Carolina. CDC is collaborating with state health departments, who are notifying and ensuring appropriate chemoprophylaxis and vaccination for exposed passengers in their jurisdiction.

Health-care providers and public health officials are advised to consider pertussis when evaluating or notified of a person with an acute illness characterized by cough with paroxysms, whoop, or post-tussive gagging or vomiting. Following are CDC guidelines on the management of patients with pertussis and their contacts:

  • For symptomatic patients, test by culture of nasopharyngeal aspirate or swab; a nasopharyngeal Dacron™ swab should be used. Swabs or aspirate should be placed in Regan Lowe transport media if direct inoculation of selective media is not possible.

  • For hospitalized patients, respiratory isolation (droplet precautions) is recommended for at least the first 5 days of antimicrobial treatment.

  • For symptomatic patients, the treatment of choice for pertussis is erythromycin for 14 days. Trimethoprim-sulfamethoxozole is an alternative antibiotic. Limited clinical data suggest that newer macrolides, such as azithromycin for 5-7 days or clarithromycin for 14 days, might be as effective as erythromycin in the treatment of pertussis and are alternatives for patients who cannot tolerate erythromycin.

  • For exposed persons, chemoprophylaxis is recommended to limit secondary transmission. Exposure is defined as having face-to-face contact, having direct contact with respiratory, oral, or nasal secretions, or being in the same room with a coughing pertussis case-patient. The recommended chemoprophylaxis regimen is erythromycin for 14 days. Alternative therapies are the same as for symptomatic patients.

  • Pertussis vaccination should be initiated or continued according to the recommended schedule for exposed children aged <7 years who are undervaccinated or who have received <4 DTaP doses. Exposed children may receive DTaP dose 2 or 3 if 4 weeks have elapsed after dose 1 or 2, respectively. Children may receive DTaP dose 4 as early as age 12 months, and preferably 6 months after dose 3. Children should be administered DTaP dose 5 unless a dose was given within the last 3 years or they are aged ≥7 years.

Additional information about pertussis is available at http://www.cdc.gov/nip/publications/pertussis/guide.htm.


L Johns, B Rowe-West, J MacCormack, MD, Div of Public Health, North Carolina Dept of Health and Human Svcs. D Kim, MD, K Murray-Lillibridge, DVM, S Maloney, MD, J Barrow, M Cetron, MD, Div of Global Migration and Quarantine, National Center for Infectious Diseases; K Bisgard, DVM, T Tiwari, MD, Epidemiology and Surveillance Div, National Immunization Program; J Shah, MD, C Ohuabunwo, MBBS, EIS Officers, CDC.




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles